EPISODE · Aug 11, 2026 · 22 MIN
The $300M Bet on the Future of Hearing with Envoy Medical - Brent Lucas | Seth Farbman’s Podcast
from Seth Farbman on Podcast - From Startup to Stock Exchange · host Seth Farbman
What does it take to build a public medtech company that's transforming the future of hearing?In this episode of Startup to Stock Exchange, Seth Farbman sits down with Brent Lucas, CEO of Envoy Medical (NASDAQ: COCH), to discuss the journey of bringing groundbreaking hearing technology to the public markets.Envoy Medical is developing the world's first fully implanted cochlear implant, a breakthrough that could redefine how people with severe hearing loss experience sound. But this conversation goes far beyond the technology.Brent shares what it takes to lead an innovative medical device company, the realities of raising capital, navigating the public markets, telling a compelling story to investors, and why having a great product alone isn't enough to build a successful public company.In this episode, you'll learn:- How Envoy Medical is reinventing hearing technology- Why the company chose to go public- The challenges of building a public medtech company- Why great products don't automatically win in the public markets- The importance of investor storytelling- How fully implanted cochlear implants could transform millions of lives- The emotional impact of helping patients reconnect with their loved onesGuest featured in this episode:Brent Lucas, CEO of Envoy Medical -https://www.linkedin.com/in/brent-lucas-envoy/Whether you're a founder, investor, healthcare professional, or simply fascinated by breakthrough innovation, this episode offers valuable insights into the intersection of technology, entrepreneurship, and the public markets.🔔 Subscribe for more conversations with founders and CEOs building the next generation of public companies.Chapters:00:00 Introducing Brent Lucas & Envoy Medical02:38 Building Invisible Hearing Technology05:14 Disrupting a 40-Year-Old Industry07:16 How Brent Got Into MedTech10:22 A 30-Year Overnight Success Story11:26 Why Envoy Medical Went Public13:01 The Reality of Going Public Through a SPAC14:38 The Challenge of Building in Public16:34 The Patient Story That Changed Everything19:36 The Public Market Challenge Nobody Talks AboutConnect with Seth LinkedIn – https://www.linkedin.com/in/sethfarbman/ Instagram – https://www.instagram.com/sethfarbmanstock TikTok – https://www.tiktok.com/@sethfarbman Twitter (X) – https://x.com/sethfarbman1
Embed this episode
What this episode covers
What does it take to build a public medtech company that's transforming the future of hearing? In this episode of Startup to Stock Exchange, Seth Farbman sits down with Brent Lucas, CEO of Envoy Medical (NASDAQ: COCH), to discuss the journey of bringing groundbreaking hearing technology to the public markets. Envoy Medical is developing the world's first fully implanted cochlear implant, a breakthrough that could redefine how people with severe hearing loss experience sound. But this conver...
Ready to play
The $300M Bet on the Future of Hearing with Envoy Medical - Brent Lucas | Seth Farbman’s Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.